Buprenorphine Market Segmentation, Global Demand Analysis, and Opportunity Outlook
Buprenorphine Market |
An
opioid called buprenorphine is used to treat both acute and chronic pain as
well as opioid use disorder. It can be injected (intravenous and subcutaneous),
applied as a patch on the skin (transdermal), placed under the tongue
(sublingual), in the cheek (buccal), or used as an implant. The distribution
channel and method of administration are used to segment the global
buprenorphine market. Due to the increasing accessibility of buprenorphine
medications in oral dose form, the sublingual route of administration is
predicted to capture the greatest market share throughout the projection
period. Furthermore, due to the rising popularity of oral medications, the
buccal category is anticipated to experience the highest market growth in the
coming years. The first two days of treatment for opioid use disorder are
typically spent under the watchful supervision of a healthcare provider after
withdrawal symptoms start to manifest.
The global Buprenorphine
Market is estimated to be valued at US$ 3,681.9 million in 2020 and is
expected to exhibit a CAGR of 14.5% during the forecast period (2020-2027).
Suboxone,
a buprenorphine/naloxone combination medication, is frequently used in the US
to stop the abuse of injectable drugs. Maximum pain relief is often attained in
an hour, and effects can last up to 24 hours. Buprenorphine has a variety of
effects on various opioid receptor types. Depending on the kind of receptor, it
might be an agonist, partial agonist, or antagonist.
A
wide variety of serious chronic diseases affect the general population,
including cancer, pain brought on by injuries, and other ailments. This is
causing people to use painkillers more frequently. The likelihood of developing
a drug addiction rises as the pain subsides. As a result, it is predicted that
buprenorphine's demand as an anti-opioid medicine would increase. An opioid
called buprenorphine is prescribed to individuals with multiple sclerosis,
cancer, or other life-threatening illnesses to manage both acute and chronic
pain. Additionally, it is anticipated that the increased incidence of cancer
would increase demand for cancer treatments, which will fuel the expansion of
the worldwide buprenorphine market. For instance, a million people were given a
cancer diagnosis in 2018, according to a factsheet from Cancer Research UK.
Comments
Post a Comment